Self-Host
Tools / Inside Trading Tracker
Inside Trading Tracker
Track insider trading activity at publicly traded companies to understand how executives are trading their shares.
Tectonic Therapeutic Inc. (TECX) Insider Trading Activity
Healthcare • Biotechnology • 44 employees
Tectonic Therapeutic, Inc., a clinical stage biotechnology company focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G-protein coupled receptors(GPCRs). It offers GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's pipeline products include RXFP1 agonist, which is in ongoing phase 1a and 1b for the indication of heart failure with preserved ejection fraction; GPCR antagonist for indication of hereditary hemorrhagic telangiectasia; bi-functional GPCR modulator for indication of fibrosis; and GPCR modulators. Tectonic Therapeutic, Inc. is based in Watertown, Massachusetts.
Total Value
$50,386,457.54
Total Shares
1,214,989
Average Trade Value
$3,875,881.35
Most Active Insider
Springer Timothy A
Total Activity: $50,076,977
Largest Single Transaction
$33,000,000
by Springer Timothy A on Feb 5, 2025
30-Day Activity
0 Transactions
Volume: 0 shares
Value: $0
|
Name
|
Position
|
Date
|
Shares
|
Value
|
Holdings
|
Type
|
|---|---|---|---|---|---|---|
| Feb 5, 2025 | 129,294 | $6,999,977 | 4,226,058 (+3.1%) | Purchase | ||
|
Chief Financial Officer
|
Feb 5, 2025 | 4,617 | $249,964 | 4,617 (+100.0%) | Purchase | |
| Feb 5, 2025 | 660,000 | $33,000,000 | 970,223 (+68.0%) | Purchase | ||
|
Chief Medical Officer
|
Feb 4, 2025 | 17,876 | $10,000 | 49,941 (+35.8%) | Grant | |
|
Chief Business Officer
|
Feb 4, 2025 | 14,023 | $0 | 18,723 (+74.9%) | Grant | |
|
Chief Executive Officer
|
Feb 4, 2025 | 36,047 | $10,000 | 214,344 (+16.8%) | Grant | |
|
Chief Scientific Officer
|
Feb 4, 2025 | 15,141 | $10,000 | 29,329 (+51.6%) | Grant | |
|
Chief Financial Officer
|
Feb 4, 2025 | 18,074 | $10,000 | 18,074 (+100.0%) | Grant | |
|
Chief Business Officer
|
Jan 28, 2025 | 2,700 | $6,426 | 4,700 (+57.4%) | Exercise/Conversion | |
|
Chief Business Officer
|
Dec 9, 2024 | 2,000 | $4,760 | 2,000 (+100.0%) | Exercise/Conversion | |
|
Chief Executive Officer
|
Dec 4, 2024 | 11,717 | $0 | 178,297 (+6.6%) | Grant | |
|
Chief Scientific Officer
|
Dec 3, 2024 | 3,500 | $8,330 | 14,188 (+24.7%) | Exercise/Conversion | |
| Oct 22, 2024 | 300,000 | $10,077,000 | 4,096,764 (+7.3%) | Purchase |